Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

Anti-inflammatory effects of RCP006--worth reposting.

"The Roskamp Institute is interested in finding new treatments for the diseases of aging associated with chronic inflammation. In this respect Roskamp Institute scientists are examining the properties of RCP006 whose active ingredient is anatabine. In further studies of NF-KB activity and anatabine's ability to decrease it, we see that LPS induced NF-KB activation in human white blood cells is decreased at dose equivalents to aspirin or celebrex (which is toxic at these doses)."

Article at:
http://www.rfdn.org/inflammaging3.html